Exhibit 99.41


    5251 Duke St., Suite 400 Tel: 902-424-7059
Duke Tower Fax: 902-424-4625
Securities P.O. Box 458 Website: nssc.novascotia.ca
Commission Halifax, Nova Scotia    
  B3J 2P8    




Immunovaccine Inc.


This is the receipt of the Nova Scotia Securities Commission for the Short Form Prospectus of the above Issuer dated June 15, 2017 (the Prospectus).


This receipt also evidences that the Ontario Securities Commission has issued a receipt for the Prospectus.


The Prospectus has been filed under Multilateral Instrument 11-102 Passport System in British Columbia, Alberta, Saskatchewan, Manitoba, Quebec and Newfoundland and Labrador. A receipt for the Prospectus is deemed to be issued by the regulator in each of those jurisdictions, if the conditions of the Instrument have been satisfied.


June 16, 2017


  (Signed) “Abel Lazarus”
  Abel Lazarus
  Acting Director of Corporate Finance
  SEDAR Project #2637829